EE200200143A - 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine - Google Patents

4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine

Info

Publication number
EE200200143A
EE200200143A EEP200200143A EEP200200143A EE200200143A EE 200200143 A EE200200143 A EE 200200143A EE P200200143 A EEP200200143 A EE P200200143A EE P200200143 A EEP200200143 A EE P200200143A EE 200200143 A EE200200143 A EE 200200143A
Authority
EE
Estonia
Prior art keywords
bile
compounds
preparation
benzylaminoquinoline
conjugates
Prior art date
Application number
EEP200200143A
Other languages
English (en)
Estonian (et)
Inventor
Hofmeister Armin
Falk Eugen
Kleeman Heinz-Werner
Jansen Hans-Willi
Bickel Martin
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999145385 external-priority patent/DE19945385A1/de
Priority claimed from DE2000128193 external-priority patent/DE10028193A1/de
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200143A publication Critical patent/EE200200143A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
EEP200200143A 1999-09-22 2000-09-06 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine EE200200143A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999145385 DE19945385A1 (de) 1999-09-22 1999-09-22 Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2000128193 DE10028193A1 (de) 2000-06-09 2000-06-09 Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente
PCT/EP2000/008691 WO2001021642A1 (de) 1999-09-22 2000-09-06 4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung

Publications (1)

Publication Number Publication Date
EE200200143A true EE200200143A (et) 2003-04-15

Family

ID=26005994

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200143A EE200200143A (et) 1999-09-22 2000-09-06 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine

Country Status (26)

Country Link
US (1) US6339077B1 (cs)
EP (1) EP1218401B1 (cs)
JP (1) JP4833471B2 (cs)
KR (1) KR20030010575A (cs)
CN (1) CN1158299C (cs)
AT (1) ATE269352T1 (cs)
AU (1) AU779412B2 (cs)
BR (1) BR0014233A (cs)
CA (1) CA2385445A1 (cs)
CZ (1) CZ2002992A3 (cs)
DE (1) DE50006842D1 (cs)
DK (1) DK1218401T3 (cs)
EE (1) EE200200143A (cs)
ES (1) ES2218222T3 (cs)
HK (1) HK1049169B (cs)
HR (1) HRP20020238A2 (cs)
HU (1) HUP0203045A3 (cs)
IL (1) IL148739A0 (cs)
NO (1) NO20021337L (cs)
NZ (1) NZ517899A (cs)
PL (1) PL353992A1 (cs)
PT (1) PT1218401E (cs)
RU (1) RU2247125C2 (cs)
SK (1) SK3862002A3 (cs)
WO (1) WO2001021642A1 (cs)
YU (1) YU19302A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
BRPI1009854A2 (pt) * 2009-03-24 2015-08-25 Abbott Lab Processo para preparar composto antiviral
WO2011123693A1 (en) * 2010-04-02 2011-10-06 Senomyx, Inc. Sweet flavor modifier
SG10201606309WA (en) 2011-08-12 2016-09-29 Senomyx Inc Sweet flavor modifier
MX394005B (es) 2014-11-07 2025-03-24 Firmenich Incorporated Acidos 4-amino-5- (ciclohexiloxi) quinolina-3-carboxilicos sustituidos como modificadores del sabor dulce.
US12186329B2 (en) 2018-08-23 2025-01-07 President And Fellows Of Harvard College Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
EP3890745A4 (en) 2018-12-04 2022-09-14 President and Fellows of Harvard College SYNTHETIC CHOLIC ACID 7-SULPHATE DERIVATIVES AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
TW289021B (cs) * 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
WO1998056757A1 (fr) * 1997-06-11 1998-12-17 Sankyo Company, Limited Derives de benzylamine

Also Published As

Publication number Publication date
JP4833471B2 (ja) 2011-12-07
EP1218401A1 (de) 2002-07-03
RU2247125C2 (ru) 2005-02-27
US6339077B1 (en) 2002-01-15
PT1218401E (pt) 2004-10-29
HRP20020238A2 (en) 2004-04-30
IL148739A0 (en) 2002-09-12
HK1049169B (zh) 2005-04-22
ATE269352T1 (de) 2004-07-15
JP2003510255A (ja) 2003-03-18
HK1049169A1 (en) 2003-05-02
DE50006842D1 (de) 2004-07-22
ES2218222T3 (es) 2004-11-16
CN1374968A (zh) 2002-10-16
NZ517899A (en) 2004-03-26
SK3862002A3 (en) 2003-01-09
NO20021337D0 (no) 2002-03-18
PL353992A1 (en) 2003-12-15
CN1158299C (zh) 2004-07-21
AU779412B2 (en) 2005-01-20
HUP0203045A3 (en) 2004-06-28
KR20030010575A (ko) 2003-02-05
YU19302A (sh) 2004-11-25
DK1218401T3 (da) 2004-10-04
HUP0203045A2 (hu) 2003-01-28
CZ2002992A3 (cs) 2002-06-12
NO20021337L (no) 2002-05-15
CA2385445A1 (en) 2001-03-29
AU7515600A (en) 2001-04-24
EP1218401B1 (de) 2004-06-16
BR0014233A (pt) 2002-05-21
WO2001021642A1 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
BR0014178A (pt) Derivados de ácido dicarboxìlico com propriedades farmacêuticas
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
GB0022438D0 (en) Organic Compounds
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
DE60103978D1 (de) Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EE200200143A (et) 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
CY1106819T1 (el) Φαρμακα για το ξηρο δερμα
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
MY126998A (en) Substituted pyrroles.
DE60022047D1 (de) Antivirale therapie
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
BRPI0417895B8 (pt) composto, processo para a preparação de um composto e uso do composto
ATE270886T1 (de) Antivirale therapie
GB9926301D0 (en) Novel compounds

Legal Events

Date Code Title Description
HB1A Correction of owner name or address